The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
Food safety advocates, who had urged the ban for decades, do not anticipate difficulties in the transition and hope this will lead to more bans on synthetic dyes. Also in public health news: baby ...